You just read:

EnGeneIC and Asbestos Diseases Research Institute Initiate MesomiR-1 Phase 1 Trial in Patients with Late Stage Mesothelioma

News provided by

EnGeneIC, Ltd.

Nov 10, 2014, 08:10 ET